| 000 | 01902 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515151850.0 | ||
| 264 | 0 | _c20090227 | |
| 008 | 200902s 0 0 eng d | ||
| 022 | _a1872-6240 | ||
| 024 | 7 |
_a10.1016/j.brainres.2008.11.057 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartin, Ludovic | |
| 245 | 0 | 0 |
_aInhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A. _h[electronic resource] |
| 260 |
_bBrain research _cFeb 2009 |
||
| 300 |
_a66-75 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCalcineurin _xmetabolism |
| 650 | 0 | 4 | _aCalcineurin Inhibitors |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 5 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 |
_aIndoles _xpharmacology |
| 650 | 0 | 4 |
_aLithium Chloride _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aOkadaic Acid _xpharmacology |
| 650 | 0 | 4 |
_aOximes _xpharmacology |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Phosphatase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRoscovitine |
| 650 | 0 | 4 |
_aTacrolimus _xpharmacology |
| 650 | 0 | 4 |
_atau Proteins _xmetabolism |
| 700 | 1 | _aMagnaudeix, Amandine | |
| 700 | 1 | _aEsclaire, Françoise | |
| 700 | 1 | _aYardin, Catherine | |
| 700 | 1 | _aTerro, Faraj | |
| 773 | 0 |
_tBrain research _gvol. 1252 _gp. 66-75 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2008.11.057 _zAvailable from publisher's website |
| 999 |
_c18524017 _d18524017 |
||